In the news | 30th March 2022
What to avoid when implementing digital solutions
Compared to most other industries, life science and biopharmaceutical companies have been slow to embrace digital technologies. Learn why in this article by Graeme Dennis, IDBS, published in Lab Manager.
European Biomanufacturing Summit 2023
Come and join us at booth 130 in Amsterdam, to learn how an innovative tech transfer approach can revolutionize drug manufacturing in the pharmaceutical industry.
IDBS events roundup: Q1 highlights and Q2 events
IDBS associates had the opportunity to attend some events in Q1 and attendees were eager to see, hear and learn more about what’s happening in the industry.
How to improve time-to-value using GxP computer systems
Explore the benefits of GxP computer systems to improve time-to-value so that companies can speed up the development and manufacture of life-saving drugs.
New process definition capabilities in PIMS enhance quality assurance and validation for pharma manufacturers
IDBS reveals new process definition-handling capabilities in PIMS 5.0, which enhance quality assurance and validation for pharma manufacturers.